A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technology

Analytical Biochemistry

Volumn 368, Issue 2, 2007, Pages 239-249

  Eveland, Suzanne S ^a   Milot, Denise P ^a   Guo, Qiu ^a   Chen, Ying ^a   Hyland, Sheryl A ^a   Peterson, Laurence B ^a   Jezequel Sur, Sylvie ^a   O'Donnell, Gregory T ^a   Zuck, Paul D ^a   Ferrer, Marc ^a   Strulovici, Berta ^a   Wagner, John A ^a   Tanaka, Wesley K ^a   Hilliard, Deborah A ^a   Laterza, Omar ^a   Wright, Samuel D ^a   Sparrow, Carl P ^a   Anderson, Matt S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cholesteryl ester transfer protein; Dabcyl; Fluorescence; HTS; Quencher; UHTSS

Indexed keywords

ANIMALS; FLUORESCENCE; LIPOPROTEINS; MICROEMULSIONS; PROTEINS;

APOLIPOPROTEIN B (APOB); CHOLESTERYL ESTER TRANSFER PROTEINS; DABCYL; HIGH-DENSITY LIPOPROTEINS; LOW DENSITY LIPOPROTEINS; QUENCHER; UHTSS; VERY LOW DENSITY LIPOPROTEINS;

ESTERS;

CARRIER PROTEIN; CHOLESTEROL ESTER;

ACCURACY; ANALYTIC METHOD; ARTICLE; CATALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLUORESCENCE; HUMAN; MICROEMULSION; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCREENING; SENSITIVITY ANALYSIS;

ANIMALIA;

EID: 34547612849     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.06.003     Document Type: Article

References (21)

1. Tall A. Plasma lipid transfer proteins. Annu. Rev. Biochem. 64 (1995) 235-257
2. Inazu A., Jiang X.C., Haraki T., Yagi K., Kamon N., Koizumi J., Mabuchi H., Takeda R., Takata K., Moriyama Y., Doi M., and Tall A.R. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest. 94 (1994) 1872-1882
3. de Grooth G.J., Kuivenhoven J.A., Stalenhoef A.F., de Graaf J., Zwinderman A.H., Posma J.L., van Tol A., and Kastelein J.J. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: A randomized phase II dose-response study. Circulation 105 (2002) 2159-2165
4. Clark R.W., Sutfin T.A., Ruggeri R.B., Willauer A.T., Sugarman E.D., Magnus-Aryitey G., Cosgrove P.G., Sand T.M., Wester R.T., Williams J.A., Perlman M.E., and Bamberger M.J. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: An initial multidose study of torcetrapib. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 490-497
5. Asztalos B.F., Cupples L.A., Demissie S., Horvath K.V., Cox C.E., Batista M.C., and Schaefer E.J. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2181-2187
6. Kannel W.B., Castelli W.P., and Gordon T. Cholesterol in the prediction of atherosclerotic disease: New perspectives based on the Framingham Study. Ann. Intern. Med. 90 (1979) 85-91
7. Black D.M. Therapeutic targets in cardiovascular disease: A case for high-density lipoprotein cholesterol. Am. J. Cardiol. 91 (2003) 40E-43E
8. Morton R.E., and Zilversmit D.B. A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. J. Biol. Chem. 256 (1981) 11992-11995
9. Bisgaier C.L., Minton L.L., Essenburg A.D., White A., and Homan R. Use of fluorescent cholesteryl ester microemulsions in cholesteryl ester transfer protein assays. J. Lipid Res. 34 (1993) 1625-1634
10. Epps D.E., Harris J.S., Greenlee K.A., Fisher J.F., Marschke C.K., Castle C.K., Ulrich R.G., Moll T.S., Melchior G.W., and Kezdy F.J. Method for measuring the activities of cholesteryl ester transfer protein (lipid transfer protein). Chem. Phys. Lipids 77 (1995) 51-63
11. Havel R.J., Eder H.A., and Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34 (1955) 1345-1353
12. Scanu A. Forms of human serum high density lipoprotein protein. J. Lipid Res. 7 (1966) 295-306
13. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985) 76-85
14. Drayna D., Jarnagin A.S., McLean J., Henzel W., Kohr W., Fielding C., and Lawn R. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327 (1987) 632-634
15. Ruggeri R.B. Cholesteryl ester transfer protein: Pharmacological inhibition for the modulation of plasma cholesterol levels and promising target for the prevention of atherosclerosis. Curr. Top. Med. Chem. 5 (2005) 257-264
16. Bai J., and Pagano R.E. Measurement of spontaneous transfer and transbilayer movement of BODIPY-labeled lipids in lipid vesicles. Biochemistry 36 (1997) 8840-8848
17. Guyard-Dangremont V., Desrumaux C., Gambert P., Lallemant C., and Lagrost L. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species: Relation to atherogenesis susceptibility. Comp. Biochem. Physiol. B 120 (1998) 517-525
18. Melchior G.W., Greenlee K.A., Castle C.K., Prough M.J., Milne R.W., Marotti K.R., and Kezdy F.J. Evidence that cynomolgus monkey cholesteryl ester transfer protein has two neutral lipid binding sites. J. Biol. Chem. 270 (1995) 21068-21074
19. Grass D.S., Saini U., Felkner R.H., Wallace R.E., Lago W.J., Young S.G., and Swanson M.E. Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans. J. Lipid Res. 36 (1995) 1082-1091
20. Marotti K.R., Castle C.K., Murray R.W., Rehberg E.F., Polites H.G., and Melchior G.W. The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism: Insights from studies with transgenic mice. Arterioscler. Thromb. 12 (1992) 736-744
21. Zhang J.H., Chung T.D., and Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4 (1999) 67-73